A Study of Adjunctive Aripiprazole in Patients With Major Depressive Disorder
Status:
Completed
Trial end date:
2006-08-01
Target enrollment:
Participant gender:
Summary
This trial is a 14 week, randomized, double-blind, placebo controlled study, to assess the
safety and efficacy of aripiprazole as adjunctive treatment to an ongoing antidepressant
treatment in patients with Major Depressive Disorder.